Ani Pharmaceuticals (ANIP) Buildings (2012 - 2013)

Ani Pharmaceuticals' (ANIP) quarterly Buildings came in at $3.7 million in Q3 2013, little changed quarter-over-quarter from $3.7 million in Q2 2013.

Ani Pharmaceuticals (ANIP) Buildings (2012 - 2013) Analysis & Trends

Ani Pharmaceuticals has disclosed Buildings across 2 years of filings, most recently posting $3.7 million for Q3 2013.

Buildings for Q3 2013 came in at $3.7 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2013 was $3.7 million (changed N/A YoY), and the FY2012 annual result was $3.7 million, changed N/A from the prior year.
Buildings came in at $3.7 million for Q3 2013 at Ani Pharmaceuticals, roughly flat from $3.7 million in the prior quarter.
In the past five years, Buildings ranged from a high of $3.7 million in Q4 2012 to a low of $3.7 million in Q4 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn
10	Ani Pharmaceuticals	1.68 Bn	1.37 Bn	143.88 Mn

Download Data